Welcome to Scribd, the world's digital library. Read, publish, and share books and documents. See more
Download
Standard view
Full view
of .
Save to My Library
Look up keyword
Like this
1Activity
0 of .
Results for:
No results containing your search query
P. 1
Dr Reddy Lab - leveraging Capabilities

Dr Reddy Lab - leveraging Capabilities

Ratings: (0)|Views: 127|Likes:
Published by Nirankar Royal
case analysis
case analysis

More info:

Categories:Types, Research
Published by: Nirankar Royal on Jul 26, 2012
Copyright:Attribution Non-commercial

Availability:

Read on Scribd mobile: iPhone, iPad and Android.
download as PPTX, PDF, TXT or read online from Scribd
See more
See less

05/13/2014

pdf

text

original

 
DRL CASE STUDY
Prepared by
 –
  Astha Bishnoi Ashutosh RanjanDiksha UniyalNikhil SharmaNirankar RoyalSwimmi Alaska
 
Basis of success of DRL prior tomid-90s
Reverse Engineering
Variant of new drug at low cost
Process innovation
Speed
Looking at drug which have high growth and lesssensitive to price fluctuation like anti-ulcerants
Indian patent act, DCPO were favorable
Two pronged approach towards export
Exported to countries where patents had expired
DRL adopted the route of exporting penultimate stageintermediates for bulk drugs
 
Contd:
Weak intellectual property rights which facilitatedreverse engineering
Methyldopa
 –
choice of product and timing of entry
Foreign exchange regulation act
Compare to US & Europe, production cost is lessin India
Produce bulk drugs where margin was good
In 1990, dropping of anti-dumping charges whichresulted in publicity
Exploitation of HW act (ANDA)

You're Reading a Free Preview

Download
/*********** DO NOT ALTER ANYTHING BELOW THIS LINE ! ************/ var s_code=s.t();if(s_code)document.write(s_code)//-->